Cargando…
Is insulin an endogenous cardioprotector?
Stress hyperglycemia and diabetes mellitus with myocardial infarction are associated with increased risk for in-hospital mortality, congestive heart failure, or cardiogenic shock. Hyperglycemia triggers free radical generation and suppresses endothelial nitric oxide generation, and thus initiates an...
Autor principal: | Das, Undurti N |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137317/ https://www.ncbi.nlm.nih.gov/pubmed/12398773 |
Ejemplares similares
-
The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro
por: Abou El Hassan, M A I, et al.
Publicado: (2003) -
Serum adipocyte fatty acid-binding protein in the critically ill
por: Das, Undurti N
Publicado: (2013) -
Can Bioactive Lipid Arachidonic Acid Prevent and Ameliorate COVID-19?
por: Das, Undurti N.
Publicado: (2020) -
A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro
por: Abou El Hassan, M A I, et al.
Publicado: (2003) -
Heart-type fatty acid-binding protein (H-FABP) and coronary heart disease
por: Das, Undurti N.
Publicado: (2016)